LU67585A1 - - Google Patents

Info

Publication number
LU67585A1
LU67585A1 LU67585A LU67585DA LU67585A1 LU 67585 A1 LU67585 A1 LU 67585A1 LU 67585 A LU67585 A LU 67585A LU 67585D A LU67585D A LU 67585DA LU 67585 A1 LU67585 A1 LU 67585A1
Authority
LU
Luxembourg
Application number
LU67585A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU67585A1 publication Critical patent/LU67585A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU67585A 1972-05-12 1973-05-11 LU67585A1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2248972A GB1436324A (en) 1972-05-12 1972-05-12 Anaesthetic 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
LU67585A1 true LU67585A1 (enExample) 1973-07-24

Family

ID=10180241

Family Applications (1)

Application Number Title Priority Date Filing Date
LU67585A LU67585A1 (enExample) 1972-05-12 1973-05-11

Country Status (13)

Country Link
US (1) US3998829A (enExample)
JP (1) JPS4948652A (enExample)
AU (1) AU474687B2 (enExample)
BE (1) BE799433A (enExample)
CA (1) CA1014947A (enExample)
DE (1) DE2323950A1 (enExample)
DK (1) DK135775B (enExample)
FR (1) FR2184711B1 (enExample)
GB (1) GB1436324A (enExample)
IE (1) IE38863B1 (enExample)
LU (1) LU67585A1 (enExample)
NL (1) NL7306606A (enExample)
ZA (1) ZA733218B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613463A (en) * 1984-11-01 1986-09-23 The Upjohn Company Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid
US5382661A (en) * 1985-09-12 1995-01-17 The Upjohn Company Pyrazinylpiperazinyl steroids
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
JPH072555Y2 (ja) * 1991-06-03 1995-01-25 日野自動車工業株式会社 車輛の前後方向兼用ウインチ
AU725214B2 (en) * 1995-06-06 2000-10-05 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
US6780853B1 (en) 1995-06-06 2004-08-24 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
US6143737A (en) * 1995-06-23 2000-11-07 Georgetown University Progesterone analogs to reverse multidrug resistance
JP2002543218A (ja) * 1999-04-29 2002-12-17 パーデュー ファーマ リミテッド 麻酔活性を有する、3α−ヒドロキシ−3βメトキシメチル−21−複素環式置換ステロイド
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
EP3572417B1 (en) 2011-10-14 2025-12-17 Sage Therapeutics, LLC 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
ES2998982T3 (en) 2013-04-17 2025-02-24 Sage Therapeutics Inc 19-nor neuroactive steroids for inducing sedation
SG10201802389SA (en) 2013-04-17 2018-04-27 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
PL3021852T3 (pl) 2013-07-19 2021-07-05 Sage Therapeutics, Inc. Neuroaktywne steroidy, kompozycje i ich zastosowania
HUE052308T2 (hu) 2013-08-23 2021-04-28 Sage Therapeutics Inc Neuroaktív szteroidok, készítmények és alkalmazásuk
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AR102306A1 (es) 2014-10-16 2017-02-15 Sage Therapeutics Inc Esteroides neuroactivos útiles en el tratamiento de enfermedades del snc
ME03809B (me) 2014-10-16 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
EP3224269B1 (en) * 2014-11-27 2020-02-26 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3250210B1 (en) 2015-01-26 2020-12-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
ES2965214T3 (es) 2016-07-11 2024-04-11 Sage Therapeutics Inc Esteroides neuroactivos sustituidos en C17, C20 y C21 y sus procedimientos de utilización
EP3481844B1 (en) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
US11643434B2 (en) 2019-05-31 2023-05-09 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1107662B (de) * 1959-07-04 1961-05-31 Merck Ag E Verfahren zur Herstellung von Mannichbasen von Steroiden bzw. von deren Saeureadditionssalzen
US3042691A (en) * 1960-05-11 1962-07-03 Pfizer & Co C 5alpha,21-dibromo-6beta-fluoro-21-methyl-pregnanes and process for making same
FR1764M (fr) * 1962-02-20 1963-04-08 Roussel Uclaf Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou viscérale.
US3201425A (en) * 1963-12-10 1965-08-17 American Cyanamid Co 20-alkoxy-delta20-21-carboxaldehydes of the pregnane series and method of preparing the same
GB1089945A (en) * 1965-09-23 1967-11-08 British Drug Houses Ltd Steroidal-6-spirocyclopropyl-4-en-3-ones
GB1317184A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Steroid-containing pharmaceutical preparations
DE1941226A1 (de) * 1969-08-13 1971-02-18 Degussa Basisch substituierte Ketosteroide
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
GB1377609A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy-5alpha-pregnane compounds
GB1416427A (en) * 1972-01-12 1975-12-03 Akzo Nv Alkylated pregnanes and process for obtaining same

Also Published As

Publication number Publication date
FR2184711B1 (enExample) 1977-01-07
DE2323950A1 (de) 1973-12-13
GB1436324A (en) 1976-05-19
IE38863B1 (en) 1978-06-21
IE38863L (en) 1973-11-12
JPS4948652A (enExample) 1974-05-11
DK135775B (da) 1977-06-20
DK135775C (enExample) 1977-11-21
BE799433A (fr) 1973-11-12
NL7306606A (enExample) 1973-11-14
US3998829A (en) 1976-12-21
CA1014947A (en) 1977-08-02
ZA733218B (en) 1974-05-29
FR2184711A1 (enExample) 1973-12-28
AU474687B2 (en) 1976-07-29
AU5561673A (en) 1974-11-14

Similar Documents

Publication Publication Date Title
DK135775C (enExample)
JPS5137651Y2 (enExample)
USB289883I5 (enExample)
JPS4952842U (enExample)
JPS5225213B2 (enExample)
JPS5525364B2 (enExample)
JPS4977880A (enExample)
JPS4933160A (enExample)
FR2175563B1 (enExample)
JPS523518Y2 (enExample)
JPS5137828B2 (enExample)
JPS5231933B2 (enExample)
JPS48100586U (enExample)
JPS4988710A (enExample)
CS154833B1 (enExample)
CS150342B1 (enExample)
CS151391B1 (enExample)
CH571208A5 (enExample)
CH580745A5 (enExample)
CH560088A5 (enExample)
CH562273A5 (enExample)
CH582265B5 (enExample)
CH562935A5 (enExample)
CH585158A5 (enExample)
CH573594A5 (enExample)